Dasotraline Completed Phase 3 Trials for Adult Attention Deficit Hyperactivity Disorder (ADHD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02160262Open-label Safety Study in Adults With ADHD
NCT02276209Dasotraline Adult ADHD Study